Markets:

Overview

News

Currencies

International

Treasuries

CVS Health Corp (NY:CVS)

79.90 +1.89 (+2.42%)

Official Closing Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

67 68 Next >

Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7 ↗

December 07, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 2-6, 2024.

Via Talk Markets

Topics Stocks / Equities

Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January ↗

December 06, 2024

Blue Shield of California launches its Pharmacy Care Reimagined Initiative with Amazon Pharmacy and Abarca in January, aiming to save $500 million annually in drug costs.

Via Benzinga

UnitedHealthcare Faces Scrutiny Amid CEO's Tragic Death, Industry Criticism ↗

December 06, 2024

UnitedHealthcare's claim denial practices are under scrutiny following the murder of CEO Brian Thompson, with criticism over its profit-driven approach to care.

Via Benzinga

13 Healthcare Sector Stocks With Healthy Valuation ↗

December 05, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...

Via Talk Markets

Topics Stocks Stocks / Equities

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market ↗

December 05, 2024

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.

Via Investor's Business Daily

Key Takeaways From CVS Health Analyst Ratings ↗

December 03, 2024

Via Benzinga

Is CVS Health Stock a Buy? ↗

December 02, 2024

Via The Motley Fool

CVS Health's Options: A Look at What the Big Money is Thinking ↗

November 29, 2024

Via Benzinga

This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

December 03, 2024

Via Benzinga

Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? ↗

November 28, 2024

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Via Benzinga

Topics Cannabis

3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost

November 26, 2024

Retail investors have a chance to break down the reasons behind the latest analyst upgrades and why they're being made in these three stocks.

Via MarketBeat

Topics Economy

Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too? ↗

November 25, 2024

Via The Motley Fool

(CVS) - Analyzing CVS Health's Short Interest ↗

November 21, 2024

Via Benzinga

Is CVS Health Stock an Underrated Buy? ↗

November 20, 2024

Via The Motley Fool

CVS Health Options Trading: A Deep Dive into Market Sentiment ↗

November 19, 2024

Via Benzinga

Analyst Expectations For CVS Health's Future ↗

November 15, 2024

Via Benzinga

Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI ↗

November 24, 2024

Wedbush Securities has issued an endorsement of the artificial intelligence software sector, with Managing Director Dan Ives predicting that 2025 will be a pivotal year for AI implementation across the...

Via Benzinga

Topics Artificial Intelligence

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields ↗

November 21, 2024

Via Benzinga

Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex' ↗

November 21, 2024

As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed...

Via Benzinga

Topics Government World Trade

Smart Money Is Betting Big In CVS Options ↗

November 08, 2024

Via Benzinga

Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System ↗

November 20, 2024

PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing.

Via Benzinga

1 Great Reason to Buy Realty Income and Hold It Forever ↗

November 20, 2024

Via The Motley Fool

CVS Health Stock Is Moving Higher Monday: What's Going On? ↗

November 18, 2024

CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.

Via Benzinga

Third Point Hedge Fund Buys Tesla, Dumps Micron ↗

November 14, 2024

Third Point filed its Form 13F on Thursday, revealing the fund's trades from the prior quarter.

Via Benzinga

2 Beaten-Down Dividend Stocks to Buy and Hold ↗

November 14, 2024

They're down, but they aren't out, at least not in the eyes of patient investors.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 13, 2024

Via Benzinga

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Looking for Passive Income? These 3 High-Yield Dividend Stocks Cut You a Check Monthly. ↗

November 09, 2024

Dividend-paying stocks consistently outperform those that don't pay a dividend.

Via The Motley Fool

Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike ↗

November 07, 2024

The U.S.

Via Benzinga

Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

November 07, 2024

Via Benzinga

Topics Government Stocks

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

67 68 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.